...and Infectious Diseases (NIAID) awarded $41.6 million over five years to University of Connecticut , The Henry M. Jackson Foundation...

...technology. SciBX 7(30); doi:10.1038/scibx.2014.895 Published online Aug. 7, 2014 Patented; m102.4 available for licensing from the Henry M. Jackson Foundation...

...planned. SciBX 5(30); doi:10.1038/scibx.2012.797 Published online Aug. 2, 2012 Patent pending; available for licensing from the Henry M. Jackson Foundation...

...monotherapy. The trial, which is expected to start next half, will also be sponsored by the Henry M. Jackson Foundation...

...12%) to $0.99 last week after the University of Texas M.D. Anderson Cancer Center and the Henry M. Jackson Foundation...

...EGFR2 ; HER2 ; ErbB2 ; neu) and sargramostim. RXi Pharmaceuticals Corp. (NASDAQ:RXII), Worcester, Mass The Henry M. Jackson Foundation...

...is majority owned by Roche, markets Herceptin in Japan. RXi Pharmaceuticals Corp. (NASDAQ:RXII), Worcester, Mass. The Henry M. Jackson Foundation...

...Published online Feb. 19, 2009 PCT patent application filed; available for licensing Contact: Carol Lavrich, The Henry M. Jackson Foundation...